A detailed history of Geneos Wealth Management Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 60,879 shares of JNJ stock, worth $8.88 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
60,879
Previous 54,576 11.55%
Holding current value
$8.88 Million
Previous $7.98 Million 23.7%
% of portfolio
0.38%
Previous 0.36%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$145.48 - $167.38 $916,960 - $1.05 Million
6,303 Added 11.55%
60,879 $9.87 Million
Q2 2024

Jul 23, 2024

BUY
$144.38 - $157.78 $2.76 Million - $3.02 Million
19,144 Added 54.03%
54,576 $7.98 Million
Q1 2024

May 03, 2024

SELL
$155.22 - $162.74 $72,022 - $75,511
-464 Reduced 1.29%
35,432 $5.6 Million
Q4 2023

Jan 26, 2024

SELL
$145.6 - $158.88 $156,374 - $170,637
-1,074 Reduced 2.91%
35,896 $5.63 Million
Q3 2023

Oct 11, 2023

BUY
$155.75 - $174.48 $225,526 - $252,647
1,448 Added 4.08%
36,970 $5.76 Million
Q2 2023

Aug 08, 2023

BUY
$154.35 - $166.11 $249,892 - $268,932
1,619 Added 4.78%
35,522 $5.88 Million
Q1 2023

Apr 25, 2023

SELL
$151.05 - $180.26 $464,780 - $554,660
-3,077 Reduced 8.32%
33,903 $5.25 Million
Q4 2022

Jan 30, 2023

BUY
$160.2 - $179.79 $127,839 - $143,472
798 Added 2.21%
36,980 $6.53 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $4.38 Million - $4.88 Million
-27,178 Reduced 42.89%
36,182 $5.91 Million
Q2 2022

Jul 22, 2022

BUY
$168.19 - $186.01 $553,513 - $612,158
3,291 Added 5.48%
63,360 $11.2 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $827,072 - $939,255
-5,230 Reduced 8.01%
60,069 $10.6 Million
Q4 2021

Feb 09, 2022

SELL
$155.93 - $173.01 $84,202 - $93,425
-540 Reduced 0.82%
65,299 $11.2 Million
Q3 2021

Nov 09, 2021

SELL
$161.5 - $179.47 $731,272 - $812,640
-4,528 Reduced 6.43%
65,839 $10.6 Million
Q2 2021

Jul 08, 2021

SELL
$159.48 - $171.07 $925,781 - $993,061
-5,805 Reduced 7.62%
70,367 $11.9 Million
Q1 2021

Jun 17, 2021

SELL
$153.07 - $170.48 $862,702 - $960,825
-5,636 Reduced 6.89%
76,172 $12.4 Million
Q4 2020

May 19, 2021

BUY
$137.11 - $157.38 $1.05 Million - $1.2 Million
7,632 Added 10.29%
81,808 $12.4 Million
Q3 2020

Sep 07, 2021

SELL
$140.38 - $153.83 $46,185 - $50,610
-329 Reduced 0.44%
74,176 $10.8 Million
Q2 2020

Sep 07, 2021

BUY
$128.81 - $155.51 $544,351 - $657,185
4,226 Added 6.01%
74,505 $10.3 Million
Q1 2020

Sep 07, 2021

SELL
$111.14 - $153.99 $85,911 - $119,034
-773 Reduced 1.09%
70,279 $8.66 Million
Q4 2019

Sep 07, 2021

BUY
$127.5 - $146.44 $56,227 - $64,580
441 Added 0.62%
71,052 $10.4 Million
Q3 2019

Sep 07, 2021

SELL
$126.95 - $142.14 $4,951 - $5,543
-39 Reduced 0.06%
70,611 $9.08 Million
Q2 2019

Sep 07, 2021

SELL
$131.15 - $144.24 $106,231 - $116,834
-810 Reduced 1.13%
70,650 $9.85 Million
Q1 2019

Sep 07, 2021

BUY
$125.72 - $139.79 $387,343 - $430,692
3,081 Added 4.51%
71,460 $9.99 Million
Q4 2018

Sep 07, 2021

BUY
$122.84 - $147.84 $121,488 - $146,213
989 Added 1.47%
68,379 $8.71 Million
Q3 2018

Sep 07, 2021

BUY
$121.58 - $142.88 $552,459 - $649,246
4,544 Added 7.23%
67,390 $9.32 Million
Q2 2018

Sep 07, 2021

SELL
$119.4 - $131.76 $896,097 - $988,858
-7,505 Reduced 10.67%
62,846 $7.63 Million
Q1 2018

Sep 07, 2021

SELL
$125.1 - $148.14 $160,503 - $190,063
-1,283 Reduced 1.79%
70,351 $9.02 Million
Q4 2017

Sep 07, 2021

BUY
$131.22 - $143.62 $202,341 - $221,462
1,542 Added 2.2%
71,634 $10 Million
Q3 2017

Sep 07, 2021

BUY
$129.47 - $135.38 $357,337 - $373,648
2,760 Added 4.1%
70,092 $9.11 Million
Q2 2017

Sep 07, 2021

BUY
N/A
3,440 Added 5.38%
67,332 $8.91 Million
Q1 2017

Sep 07, 2021

BUY
N/A
2,325 Added 3.78%
63,892 $7.96 Million
Q4 2016

Sep 07, 2021

BUY
N/A
787 Added 1.29%
61,567 $7.09 Million
Q3 2016

Sep 07, 2021

SELL
N/A
-207 Reduced 0.34%
60,780 $7.18 Million
Q2 2016

Sep 07, 2021

BUY
N/A
576 Added 0.95%
60,987 $7.4 Million
Q1 2016

Sep 07, 2021

BUY
N/A
60,411
60,411 $6.6 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.